{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:10:07Z","timestamp":1750050607206,"version":"3.41.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,15]]},"DOI":"10.7759\/cureus.86093","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T04:46:24Z","timestamp":1750049184000},"source":"Crossref","is-referenced-by-count":0,"title":["Defying the Odds: Small Cell Lung Cancer with Essential Thrombocythemia and Secondary Cancers"],"prefix":"10.7759","author":[{"given":"Mathew","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathon","family":"Vundum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Mani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israfil","family":"Baluwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi AT 3rd","year":"1999","unstructured":"Turrisi AT 3rd, Kim K, Blum R, et al.. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999, 340:265-71. 10.1056\/NEJM199901283400403","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Small cell lung cancer","volume":"11","author":"Kalemkerian GP","year":"2013","unstructured":"Kalemkerian GP, Akerley W, Bogner P, et al.. Small cell lung cancer. J Natl Compr Canc Netw. 2013, 11:78-98.","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1816082","article-title":"Essential thrombocythemia","volume":"381","author":"Tefferi A","year":"2019","unstructured":"Tefferi A, Pardanani A. Essential thrombocythemia. N Engl J Med. 2019, 381:2135-44. 10.1056\/NEJMcp1816082","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?","volume":"119","author":"Hasselbalch HC","year":"2012","unstructured":"Hasselbalch HC. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?. Blood. 2012, 119:3219-3225. 10.1182\/blood-2011-11-394775","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares L","year":"2019","unstructured":"Paz-Ares L, Dvorkin M, Chen Y, et al..  Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.  Lancet. 2019, 394: 1929-39. 10.1016\/S0140-6736(19)32222-6","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0410-9","article-title":"Advances in SCLC therapy","volume":"18","author":"Rudin CM","year":"2021","unstructured":"Rudin CM, Poirier JT, Byers LA, et al.. Advances in SCLC therapy. Nat Rev Clin Oncol. 2021, 18:85-96. 10.1038\/s41571-020-0410-9","journal-title":"Nat Rev Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-102665","article-title":"Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: A retrospective survey","volume":"111","author":"Ruggeri M","year":"2008","unstructured":"Ruggeri M, Rodeghiero F, Tosetto A, et al.. Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: A retrospective survey. Blood. 2008, 111:666-71. 10.1182\/blood-2007-07-102665","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0027-y","article-title":"Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients","volume":"32","author":"Landtblom AR","year":"2018","unstructured":"Landtblom AR, Bower H, Andersson TM, et al.. Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients. Leukemia. 2018, 32:2203-10. 10.1038\/s41375-018-0027-y","journal-title":"Leukemia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/357505-defying-the-odds-small-cell-lung-cancer-with-essential-thrombocythemia-and-secondary-cancers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T04:46:25Z","timestamp":1750049185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/357505-defying-the-odds-small-cell-lung-cancer-with-essential-thrombocythemia-and-secondary-cancers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.86093","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,15]]}}}